- Home
- PHAT vs HCKT Comparison
PHAT vs HCKT Comparison
Compare PHAT & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- HCKT
- Stock Information
- Founded
- PHAT 2018
- HCKT 1991
- Country
- PHAT United States
- HCKT United States
- Employees
- PHAT N/A
- HCKT N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- HCKT Professional Services
- Sector
- PHAT Health Care
- HCKT Consumer Discretionary
- Exchange
- PHAT Nasdaq
- HCKT Nasdaq
- Market Cap
- PHAT 716.5M
- HCKT 636.1M
- IPO Year
- PHAT 2019
- HCKT 1998
- Fundamental
- Price
- PHAT $11.91
- HCKT $21.09
- Analyst Decision
- PHAT Strong Buy
- HCKT Strong Buy
- Analyst Count
- PHAT 5
- HCKT 3
- Target Price
- PHAT $16.40
- HCKT $29.67
- AVG Volume (30 Days)
- PHAT 1.1M
- HCKT 361.4K
- Earning Date
- PHAT 08-07-2025
- HCKT 08-05-2025
- Dividend Yield
- PHAT N/A
- HCKT 2.32%
- EPS Growth
- PHAT N/A
- HCKT N/A
- EPS
- PHAT N/A
- HCKT 0.59
- Revenue
- PHAT $114,039,000.00
- HCKT $309,265,000.00
- Revenue This Year
- PHAT $194.40
- HCKT $6.06
- Revenue Next Year
- PHAT $103.23
- HCKT $5.46
- P/E Ratio
- PHAT N/A
- HCKT $35.01
- Revenue Growth
- PHAT 1049.82
- HCKT 3.98
- 52 Week Low
- PHAT $2.21
- HCKT $19.39
- 52 Week High
- PHAT $19.71
- HCKT $34.02
- Technical
- Relative Strength Index (RSI)
- PHAT 75.25
- HCKT 42.97
- Support Level
- PHAT $9.82
- HCKT $19.93
- Resistance Level
- PHAT $11.19
- HCKT $20.82
- Average True Range (ATR)
- PHAT 0.71
- HCKT 0.72
- MACD
- PHAT 0.17
- HCKT 0.03
- Stochastic Oscillator
- PHAT 94.07
- HCKT 43.70
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.